Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Zhou, Zhao Hua ^a   Wild, Teresa ^b   Xiong, Ying ^b   Sylvers, Peter ^a   Zhang, Yahong ^b   Zhang, Luxia ^b   Wahl, Larry ^b   Wahl, Sharon M ^b   Kozlowski, Steven ^a   Notkins, Abner L ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; ANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN M;

ANIMAL; APOPTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; RADIATION RESPONSE; T LYMPHOCYTE; ULTRAVIOLET RADIATION; ARTICLE; RADIATION EXPOSURE;

ANAPHYLATOXINS; ANIMALS; ANTIBODIES; APOPTOSIS; COMPLEMENT C5A; COMPLEMENT SYSTEM PROTEINS; HIV; HUMANS; IMMUNOGLOBULIN M; MACROPHAGES; MICE; PHAGOCYTOSIS; T-LYMPHOCYTES; ULTRAVIOLET RAYS;

EID: 84894503603     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02271     Document Type: Article

References (44)

1. Tauber, A. I. & Podolsky, S. H. The Generation of Diversity: Clonal Selection Theory and the Rise of Molecular Immunology, (Harvard University Press, Cambridge, MA, 1997).
2. Satoh, J., Prabhakar, B. S., Haspel, M. V., Ginsberg-Fellner, F. & Notkins, A. L. Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med 309, 217-220 (1983).
3. Casali, P. & Notkins, A. L. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD51 B lymphocytes. Annu Rev Immunol 7, 513-535 (1989).
4. Coutinho, A., Kazatchkine, M. D. & Avrameas, S. Natural autoantibodies. Curr Opin Immunol 7, 812-818 (1995).
5. Notkins, A. L. Polyreactivity of antibody molecules. Trends Immunol 25, 174-179 (2004).
6. Prabhakar, B. S., Saegusa, J., Onodera, T. &Notkins, A. L. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 133, 2815-2817 (1984).
7. Dighiero, G. et al. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 131, 2267-2272 (1983).
8. Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C. & Chen, J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188, 2381-2386 (1998).
9. Ochsenbein, A. F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159 (1999).
10. Quan, C. P., Berneman, A., Pires, R., Avrameas, S. & Bouvet, J. P. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 65, 3997-4004 (1997).
11. Zhou, Z. H. et al. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1, 51-61 (2007).
12. Mouquet, H. & Nussenzweig, M. C. Polyreactive antibodies in adaptive immune responses to viruses. Cell Mol Life Sci 69, 1435-1445 (2012).
13. Ichiyoshi, Y., Zhou, M. & Casali, P. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and sitedirected mutagenesis. J Immunol 154, 226-238 (1995).
14. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
15. Zhou, Z. H., Tzioufas, A. G. & Notkins, A. L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29, 219-228 (2007).
16. Haspel, M. V. et al. Multiple organ-reactive monoclonal autoantibodies. Nature 304, 73-76 (1983).
17. Chen, Z. J. et al. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol 28, 989-994 (1998).
18. Zhou, Z. H. & Notkins, A. L. Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-11 and B-12 phenotypes. Clin Exp Immunol 137, 88-100 (2004).
19. Renehan, A. G., Booth, C. & Potten, C. S. What is apoptosis, and why is it important? BMJ 322, 1536-1538 (2001).
20. Notley, C. A., Brown, M. A., Wright, G. P. & Ehrenstein, M. R. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol 186, 4967-4972 (2011).
21. Nagata, S., Hanayama, R. & Kawane, K. Autoimmunity and the clearance of dead cells. Cell 140, 619-630 (2010).
22. Gronwall, C. et al. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin Immunol 142, 390-398 (2012).
23. Grimsley, C. & Ravichandran, K. S. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol 13, 648-656 (2003).
24. Ehrenstein, M. R. & Notley, C. A. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10, 778-786 (2010).
25. Fu, M. et al. Identification of poly-reactive natural IgM antibody that recognizes late apoptotic cells and promotes phagocytosis of the cells. Apoptosis 12, 355-362 (2007).
26. Kim, J. Identification of a human monoclonal natural IgM antibody that recognizes early apoptotic cells and promotes phagocytosis. Hybridoma (Larchmt) 29, 275-281 (2010).
27. Quartier, P., Potter, P. K., Ehrenstein, M. R., Walport, M. J. & Botto, M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol 35, 252-260 (2005).
28. Munoz, L. E., Lauber, K., Schiller, M.,Manfredi, A. A.&Herrmann,M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6, 280-289 (2010).
29. Gaipl, U. S. et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 28, 114-121 (2007).
30. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495-516 (2007).
31. Henson, P. M. & Hume, D. A. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 27, 244-250 (2006).
32. Li, C. J., Friedman, D. J., Wang, C., Metelev, V. & Pardee, A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268, 429-431 (1995).
33. Tomer, Y. & Shoenfeld, Y. The significance of natural autoantibodies. Immunol Invest 17, 389-424 (1988).
34. Grabar, P. Autoantibodies and the physiological role of immunoglobulins. Immunology Today 4, 337-340 (1983).
35. Stafford, P. et al. Physical characterization of the "immunosignaturing effect". Mol Cell Proteomics 11, M111 011593 (2012).
36. Shaw, P. X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105, 1731-1740 (2000).
37. Gronwall, C., Vas, J. & Silverman, G. J. Protective Roles of Natural IgM Antibodies. Front Immunol 3, 66 (2012).
38. Kaveri, S. V. Intravenous immunoglobulin: Exploiting the potential of natural antibodies. Autoimmun Rev 11, 792-794 (2012).
39. Sapir, T. & Shoenfeld, Y. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol 29, 185-199 (2005).
40. Bruley-Rosset, M. et al. Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseases. Lab Invest 83, 1013-1023 (2003).
41. Kaveri, S. V., Silverman, G. J. & Bayry, J. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol 188, 939-945 (2012).
42. Ardans, J. A., Economou, A. P., Martinson, J. M, Jr., Zhou, M. & Wahl, L. M. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes. J Leukoc Biol 71, 1012-1018 (2002).
43. Moutsopoulos, N. M. et al. Regulation of the tonsil cytokine milieu favors HIV susceptibility. J Leukoc Biol 80, 1145-1155 (2006).
44. Phanse, Y. et al.Analyzing cellular internalization of nanoparticles and bacteria by multi-spectral imaging flow cytometry. J Vis Exp, e3884 (2012).